From: Effects of RNA methylation on Tumor angiogenesis and cancer progression
Type | Molecule | Role in tumors | Tumor type | Mechanism | References |
---|---|---|---|---|---|
Writers | METTL3 | Oncogene | Bladder cancer | Promote angiogenesis via modulating TEK and VEGF-A | [72] |
 |  | Oncogene | GC | Promote angiogenesis via stimulating m6a modification of HDGF mRNA | [58] |
 |  | Oncogene | HCC | Promote angiogenesis via modulating Hippo pathway | [57] |
 |  | Oncogene | RCC | Promote angiogenesis via modulating HIF-2α | [73] |
 | METTL14 | Oncogene | Breast cancer | Promote angiogenesis via modulating VEGFA and RhoA and PI3K-Akt pathways | [27] |
Erasers | FTO | Suppressor gene | ICC | FTO expression is inversely correlated with MVD. | [45] |
 | ALKBH5 | Oncogene | Breast cancer | Promote angiogenesis via modulating VEGFA and RhoA and PI3K-Akt pathways | [27] |
Readers | IGF2BP2 | Oncogene | Lung cancer | Promote angiogenesis via modulating HNF4G/IGF2BP2/TK1 axis | [74] |
 | IGF2BP3 | Oncogene | GC | Promote angiogenesis via enhancing HDGF mRNA stability | [58] |
 |  | Oncogene | CRC | Promote angiogenesis via modulating VEGF | [39] |
 |  | Oncogene | GBM | Promote angiogenesis via modulating PI3K/MAPK pathways | [75] |
 | YTHDF1 | Oncogene | GC | Promote angiogenesis via modulating Wnt/β-catenin pathway | [32] |
 | YTHDF2 | Suppressor gene | HCC | Suppress angiogenesis via downregulating IL11 and SERPINE2 | [70] |
 | YTHDF3 | Oncogene | Breast cancer | Promote angiogenesis via modulating VEGFA and EGFR | [71] |